GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enanta Pharmaceuticals Inc (FRA:9EP) » Definitions » Other Gross PPE

Enanta Pharmaceuticals (FRA:9EP) Other Gross PPE : €86.92 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Enanta Pharmaceuticals Other Gross PPE?

Enanta Pharmaceuticals's Other Gross PPE for the quarter that ended in Dec. 2024 was €86.92 Mil.

Enanta Pharmaceuticals's quarterly Other Gross PPE declined from Jun. 2024 (€65.99 Mil) to Sep. 2024 (€63.37 Mil) but then increased from Sep. 2024 (€63.37 Mil) to Dec. 2024 (€86.92 Mil).

Enanta Pharmaceuticals's annual Other Gross PPE increased from Sep. 2022 (€46.09 Mil) to Sep. 2023 (€49.18 Mil) and increased from Sep. 2023 (€49.18 Mil) to Sep. 2024 (€63.37 Mil).


Enanta Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for Enanta Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enanta Pharmaceuticals Other Gross PPE Chart

Enanta Pharmaceuticals Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.90 22.40 46.09 49.18 63.37

Enanta Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.69 53.70 65.99 63.37 86.92

Enanta Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Enanta Pharmaceuticals Business Description

Traded in Other Exchanges
Address
4 Kingsbury Avenue, Watertown, MA, USA, 02472
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Enanta Pharmaceuticals Headlines

No Headlines